Prof. Nicholas Turner | |
|---|---|
| Born | Nicholas John Turner 1959 or 1960 (age 63–64)[7] |
| Alma mater | University of Bristol[8] (Bsc.) University of Oxford[8](PhD) |
| Known for | Biotechnology Cell biology Biocatalysis Organic synthesis |
| Awards | |
| Scientific career | |
| Fields | Biochemistry Organic chemistry |
| Institutions | The University of Manchester |
| Thesis | Mechanistic studies on isopenicillin N synthase (1985) |
| Doctoral advisor | Prof. Sir. Jack Baldwin |
Nicholas John Turner, FRS is a British chemist and a Professor in the Department of Chemistry at The University of Manchester.[8] His research in general is based on biochemistry and organic chemistry, specifically on biotechnology, cell biology, biocatalysis and organic synthesis.[9][10]
Turner completed his Bachelor of Science degree in Chemistry in 1982 at University of Bristol.[8] He then read for his Doctor of Philosophy degree at University of Oxford on Mechanistic studies on isopenicillin N synthase and successfully completed it in 1985.[11] His PhD was supervised by Prof. Sir. Jack Baldwin.[11]
Upon completing his PhD, Turner spent two years (1985 - 1987) with Prof. George M. Whitesides at Harvard University as a Royal Society Junior Research Fellow.[8][12] He then moved to University of Exeter as a Lecturer in 1987, before moving to University of Edinburgh for the position of Reader in 1995.[12] He was promoted to the position of Professor in 1998 and moved to University of Manchester as a Professor of Chemical Biology in 2004.
Turner's research in general is based on biochemistry and organic chemistry, specifically on biotechnology, cell biology, biocatalysis and organic synthesis.[9][10]
Turner is the Director of CoEBio3, an organization designed to provide scientific environment in which the necessary research and development can be carried out to create new biocatalyst-based processes to meet the changing needs of industry in the next 10–20 years.[13] He is also the Co-founder of Ingenza and Co-director of SYNBIOCHEM.[14][15] Turner is also the author of several books in the field of biocatalysis including Introduction to Biocatalysis Using Enzymes and Microorganisms,[16] and Biocatalysis in Organic Synthesis: The Retrosynthesis Approach.[17]
Turner was elected as a Fellow of the Royal Society in the year 2020.[6] Regarded one of the world's leading researchers[6] in the field of Biocatalysis, his profile reads:
"Nicholas Turner undertakes research focussed on creating new enzymes for application as biocatalysts for chemical synthesis.[18][19][20] His group combine enzyme discovery with protein engineering and directed evolution methods in order to develop biocatalysts with tailored properties including high (stereo)selectivity, improved activity and enhanced stability. These biocatalysts, which include amine/alcohol oxidases, imine reductases, lyases, transaminases and monooxygenases, are then applied to the synthesis of a range of target molecules especially pharmaceuticals and fine chemicals.[21][22] ... Nick also has a passion for promoting the wider application of biocatalysis across the entire chemical community and has developed guidelines for 'biocatalytic retrosynthesis'[17] to encourage greater adoption of biocatalysis amongst synthetic chemists."